Conference
Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases.
Abstract
390
Background: An increasing proportion of patients with liver CAM are undergoing hepatic resection with curative intent. Detection of occult metastastic disease is important in this setting, and PET/CT is used to identify patients with either inoperable, or limited resectable extrahepatic disease not identified with conventional imaging. We recently reported the results related to the primary objective of PETCAM, a …
Authors
Moulton C-A; Levine MN; Law C; Hart R; Ruo L; Gu C-S; Hendler A; Gulenchyn KY; Haider MA; Marcaccio M
Volume
30
Pagination
pp. 390-390
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2012
DOI
10.1200/jco.2012.30.4_suppl.390
Conference proceedings
Journal of Clinical Oncology
Issue
4_suppl
ISSN
0732-183X